Welcome to LookChem.com Sign In|Join Free
  • or
2-methyl-1,6-naphthyridine is a heterocyclic organic compound with the molecular formula C10H8N2. It is a derivative of the parent compound 1,6-naphthyridine, which is a six-membered aromatic ring with one nitrogen atom at each end. The 2-methyl-1,6-naphthyridine has a methyl group attached to the second carbon atom of the ring, which influences its chemical properties and reactivity. 2-methyl-1,6-naphthyridine is often used as a building block in the synthesis of various pharmaceuticals and agrochemicals due to its unique structure and potential to form stable complexes with other molecules. Its chemical properties, such as its basicity and reactivity towards electrophiles, make it a valuable intermediate in organic synthesis.

7675-31-2

Post Buying Request

7675-31-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7675-31-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 7675-31-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,6,7 and 5 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 7675-31:
(6*7)+(5*6)+(4*7)+(3*5)+(2*3)+(1*1)=122
122 % 10 = 2
So 7675-31-2 is a valid CAS Registry Number.

7675-31-2Relevant academic research and scientific papers

HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF

-

Page/Page column 144, (2011/12/14)

Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes

BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF GLYTL MEDIATED DISORDERS

-

Page/Page column 106, (2011/02/24)

The present invention relates to benzoxazinone derivatives, processes for their preparation, pharmaceutical compositions and medicaments containing them and to their use in treating disorders mediated by GlyT1, including neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 7675-31-2